Skip to main content

Bio3DModel

ServiceFlorence, ItalyFounded 2020· One of 2028 Service companies tracked by AMPulse

Provides 3D printing services, software, and training for medical applications, including anatomical models and bioprinted tissues, to support personalized medicine.

CEO / Founder
Giovan Battista Semplici
Stage
Established
Key Investors
Parent company/corporate backer identified: SolidWorld Group (publicly listed holding company; per its FY2024 (FY24) investor results presentation, Bio3DModel is one of its subsidiaries requiring substantial R&D investment, alongside T&D). Additionally, Bio3DModel is undergoing a merger with Bio3DPrinting (merger project approved, announced via LinkedIn), indicating consolidation within the SolidWorld Group corporate structure rather than traditional VC/investor backing.

Technology & Products

Key Products

3D printing services for medical applications, including anatomical models and bioprinted tissues. Collaborated on the development of Electrospider, a 3D cell bioprinter.

Technological Advantage

Proprietary bioprinting technology (Electrospider) capable of replicating human cell tissues, combined with Stratasys-certified healthcare specialization and ISO 13485 certification, creating a defensible regulatory and technological moat.

Differentiation

Value Proposition

Reduces hospitalization costs by up to 70% through patient-specific anatomical models and surgical guides, enabling less invasive procedures and improved surgical planning.

How They Differentiate

Focuses exclusively on medical applications with ISO 13485 certification and integrated bioprinting, unlike broader industrial AM competitors; offers end-to-end services including training and software, whereas many competitors are hardware-focused.

Market & Competition

Target Customers

Hospitals, clinics, research institutions, medical device companies

Industry Verticals

Healthcare; Medical Devices; Biotechnology

Competitors

BICO; 3D Systems; Desktop Metal

Growth & Milestones

Growth Metrics

ISO 13485 certification, collaboration with universities and hospitals, expansion into medical sector

Major Milestones

ISO 13485 certification obtained; Merger with Bio3DPrinting in 2026; Launch of Electrospider bioprinter

Notable Customers

San Giovanni di Dio di Firenze

Equipment deals on record

Publicly disclosed purchases or installs only.

  • J750 Digital AnatomyBuyer: BIO3DModel · Supplier: Stratasys
View full equipment ledger